HDAC2-mediated chromatin remodeling drives hepatocellular carcinoma progression: an integrative analysis of computational pathology and multi-transcriptomics

Shu‐Yi Yin; Xuancheng Zhou; Lai Jiang; Yuheng Gu; Jingjing Dai; Haiqing Chen; Shengke Zhang; Jiaan Lu; Gang Huang; Yuxuan Jiang; Xinting Sang; Kun Yuan; Hua Yang; Guanhu Yang; Shangke Huang; Hao Chi; Ke Xu

doi:10.1186/s12967-025-07517-9

Affiliated Institutions

Related Publications

How Proteolysis Drives the Cell Cycle

Randall W. King , Raymond J. Deshaies , Jan‐Michael Peters +1 more

Oscillations in the activity of cyclin-dependent kinases (CDKs) promote progression through the eukaryotic cell cycle. This review examines how proteolysis regulates CDK activit...

1996 Science 1275 citations

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng , Yoon‐Koo Kang , Zhendong Chen +18 more

Most cases of hepatocellular carcinoma occur in the Asia-Pacific region, where chronic hepatitis B infection is an important aetiological factor. Assessing the efficacy and safe...

2008 The Lancet Oncology 5750 citations

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu , Yoon‐Koo Kang , Chia‐Jui Yen +21 more

Patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations have poor prognosis. We aimed to establish the efficacy of ramucirumab in patien...

2019 The Lancet Oncology 1593 citations

ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis

Jeffrey M. Granja , M. Ryan Corces , Sarah E. Pierce +4 more

Abstract The advent of single-cell chromatin accessibility profiling has accelerated the ability to map gene regulatory landscapes but has outpaced the development of scalable s...

2021 Nature Genetics 1260 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

HDAC2-mediated chromatin remodeling drives hepatocellular carcinoma progression: an integrative analysis of computational pathology and multi-transcriptomics

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Shu‐Yi Yin, 
                                
                                    Xuancheng Zhou, 
                                
                                    Lai Jiang
                                
                                et al.
                            
                            (2025). 
                            HDAC2-mediated chromatin remodeling drives hepatocellular carcinoma progression: an integrative analysis of computational pathology and multi-transcriptomics. 
                            Journal of Translational Medicine
                            
                            .
                            https://doi.org/10.1186/s12967-025-07517-9

Identifiers

DOI: 10.1186/s12967-025-07517-9